Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
120,4 USD | -0,07% | -3,50% | -2,10% |
25/03 | JAZZ PHARMACEUTICALS PLC : JPMorgan Chase nog altijd een koopadvies | ZM |
21/03 | JAZZ PHARMACEUTICALS PLC : Piper Sandler bevestigt koopadvies | ZM |
Omzet 2024 * | 4,1 mld. 3,8 mld. | Omzet 2025 * | 4,39 mld. 4,07 mld. | Marktkapitalisatie | 7,51 mld. 6,96 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 481 mln. 446 mln. | Nettowinst (verlies) 2025 * | 649 mln. 602 mln. | EV/omzet 2024 * | 2,57 x |
Nettoschuld 2024 * | 3 mld. 2,78 mld. | Nettoschuld 2025 * | 1,61 mld. 1,49 mld. | EV/omzet 2025 * | 2,08 x |
K/w-verhouding 2024 * |
18,1
x | K/w-verhouding 2025 * |
12,3
x | Werknemers | 2.800 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,18% |
Recentste transcriptie over Jazz Pharmaceuticals plc
1 dag | -0,07% | ||
1 week | -3,50% | ||
Lopende maand | +1,28% | ||
1 maand | -8,95% | ||
3 maanden | -1,63% | ||
6 maanden | -8,24% | ||
Lopend jaar | -2,10% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01-03-03 |
Renée Galá
PSD | President | 52 | 16-03-20 |
Robert Iannone
CTO | Chief Tech/Sci/R&D Officer | 57 | 29-05-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01-03-03 |
Norbert Riedel
BRD | Director/Board Member | 66 | 13-05-13 |
Patrick Enright
BRD | Director/Board Member | 62 | 01-01-09 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
19.34% | 13 M€ | -.--% | ||
14.47% | 227 M€ | +6,28% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 120,4 | -0,07% | 403 506 |
27-03-24 | 120,5 | +2,19% | 471 653 |
26-03-24 | 117,9 | -2,37% | 1 689 780 |
25-03-24 | 120,8 | -0,84% | 597 609 |
22-03-24 | 121,8 | -1,85% | 691 817 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,10% | 7,51 mld. | |
+33,46% | 701 mld. | |
+26,24% | 571 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-3,61% | 157 mld. |